Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Wellness starts with trust, and that trust is built through transparency
Design of antagonists for NMDA and AMPA receptors
, 41 , 1119-1132, doi: Funding This work was financially supported by the Program 5-100 of the Peoples Friendship University of Russia
Adverse Reactions (6.1).] Sitagliptin Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on the Combination of Metformin and Rosiglitazone A total of 278 patients with type 2 diabetes participated in a 54-week, randomized, double-blind, placebo-controlled study designed to assess the efficacy of sitagliptin in combination with metformin and rosiglitazone
US$ 26.25
US$ 26.62
US$ 27.20
US$ 28.24
US$ 24.44
US$ 21.31
US$ 27.00
US$ 22.39
US$ 20.21
US$ 29.75
US$ 29.00
US$ 20.75
US$ 20.27
US$ 24.23
